Publication Details
Abstract
Liver diseases, particularly toxic hepatitis, remain a major global health concern due to their high morbidity and mortality rates. Exposure to hepatotoxins such as carbon tetrachloride (CCl4) can lead to severe liver damage, necessitating the development of effective hepatoprotective agents. Despite advancements in medical therapy, there is still a need for natural or bioactive compounds that can mitigate liver injury. The M-1 bioactive supplement has shown potential hepatoprotective properties, yet its efficacy needs thorough scientific validation. Animal models are widely used to investigate the therapeutic potential of bioactive compounds against chemically induced liver toxicity. The current study aims to evaluate the hepatoprotective effects of M-1 in an experimental model of acute toxic hepatitis. The findings of this study could contribute to the development of new strategies for liver disease management.